Biotech Company Focused on Hair Loss Sees Stock IPO Surge Despite Lack of Revenue.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 04 2026
0mins
Should l Buy GEMI?
Source: Barron's
Company Overview: Veradermics is a small biotechnology firm focused on developing drugs for hair loss.
Stock Market Performance: The company had a successful debut on Wall Street, with shares opening at $33, peaking at $40.01, and closing at $37.75, marking a 122% increase from its initial offering price of $17.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GEMI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GEMI
Wall Street analysts forecast GEMI stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 4.110
Low
11.00
Averages
18.78
High
26.00
Current: 4.110
Low
11.00
Averages
18.78
High
26.00
About GEMI
Gemini Space Station, Inc. is a holding company. The Company, through its subsidiary, Gemini Space Station, LLC, offers a mobile and Web-based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, high-performance over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The Company operates globally and provides security solutions across all of its product offerings. Its platform simplifies and secures the process of buying, selling, storing, staking, and collecting digital assets. It provides accessible and straightforward educational resources to help its users understand the intricacies of crypto assets. Its Gemini Credit Card, an innovative credit card made available by Gemini, allows users to earn and grow crypto rewards every time they swipe.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Lawsuit Background: Hagens Berman has filed a securities class action against Gemini Space Station, Inc., alleging that the company concealed an impending corporate pivot in its IPO documents, resulting in a stock price decline of over 75% from its IPO price.
- Legal Action Details: The lawsuit seeks to recover losses for investors who purchased Gemini stock during or traceable to the September 12, 2025 IPO, with a critical deadline of May 18, 2026, for investors to apply as Lead Plaintiff.
- Disclosure Issues: The complaint alleges that Gemini made material misstatements and omitted critical information in its IPO materials, misleading investors about the company's focus on international exchange growth while failing to disclose a shift towards prediction markets.
- Whistleblower Program: Hagens Berman encourages individuals with non-public information to consider the SEC Whistleblower program, which offers rewards of up to 30% of any successful recovery, thereby enhancing the investigation into Gemini's practices.
See More
- Lawsuit Announcement: Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities fraud class action lawsuit against Gemini Space Station, Inc., representing investors who purchased shares during the IPO on September 12, 2025, and up to February 17, 2026, indicating that investors can apply to be lead plaintiff by May 18, 2026.
- Stock Price Volatility: Following Gemini's announcement on February 5, 2026, regarding a 25% workforce reduction and exit from several markets, its Class A common stock price fell by $0.64, or 8.72%, closing at $6.70, reflecting strong market reaction to the strategic pivot.
- Executive Departures Impact: On February 17, 2026, Gemini announced the departure of its COO, CFO, and Chief Legal Officer, alongside preliminary financial results showing a 40% increase in operating expenses, leading to a further stock price drop of $0.97, or 12.9%, to $6.585, highlighting instability in corporate governance.
- Post-IPO Price Collapse: At the time the lawsuit was filed, Gemini's Class A common stock traded at $5.96, representing a staggering 78.7% decline from its IPO price of $28.00, indicating extreme investor pessimism regarding the company's future prospects.
See More
- Lawsuit Announcement: Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities fraud class action lawsuit against Gemini Space Station, Inc., concerning shares purchased during the IPO on September 12, 2025, and thereafter, with investors having until May 18, 2026, to apply as lead plaintiffs, highlighting significant investor concerns regarding the company's financial transparency.
- Stock Price Volatility: Following the announcement of the 'Gemini 2.0' strategic pivot, Gemini's Class A common stock fell by 8.72% to close at $6.70 per share on February 5, 2026, reflecting market unease and a lack of confidence in the company's future direction.
- Executive Departures Impact: On February 17, 2026, Gemini announced the departure of its COO, CFO, and Chief Legal Officer, alongside a preliminary estimate indicating a 40% increase in operating expenses for 2025, leading to a further 12.9% drop in stock price to $6.585 per share, suggesting that governance instability may undermine investor confidence.
- Post-IPO Stock Decline: At the time the lawsuit was filed, Gemini's Class A common stock traded at $5.96 per share, representing a staggering 78.7% decline from the IPO price of $28.00, indicating extreme pessimism among investors regarding the company's future prospects and potential legal and financial repercussions.
See More
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Gemini Space Station, Inc., particularly focusing on investors who purchased securities during the IPO on September 12, 2025, and thereafter.
- Investor Rights Reminder: The firm reminds investors that May 18, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, making this date critical for affected investors.
- Contact Information Provided: Securities Litigation Partner Josh Wilson encourages affected investors to reach out directly, providing phone numbers for discussions on legal options, demonstrating a commitment to client support.
- Potential Market Impact: The ongoing legal investigation may lead to further volatility in Gemini's stock, prompting investors to closely monitor developments to safeguard their interests.
See More
- Class Action Initiation: Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Gemini Space Station, Inc. in the Southern District of New York, concerning purchases of Gemini Class A common stock from September 12, 2025, to February 17, 2026, highlighting significant investor concerns regarding the company's financial transparency.
- Significant Stock Drop: Following the announcement of a 25% workforce reduction and exit from several international markets, Gemini's stock price fell by 8.72% to $6.70 per share on February 5, 2026, reflecting strong market unease about the company's future operational model.
- Deteriorating Financial Condition: On February 17, 2026, preliminary financial results revealed a 40% increase in operating expenses, leading to a further 12.9% drop in stock price to $6.585 per share, indicating severe financial pressure and restructuring risks facing the company.
- Investor Action Guidance: Investors are encouraged to apply for lead plaintiff status by May 18, 2026, to represent all affected investors in the class action, underscoring the urgent need for improved corporate governance and transparency to protect investor interests.
See More
- Lawsuit Background: A securities fraud class action lawsuit has been filed by Kessler Topaz Meltzer & Check, LLP against Gemini Space Station, Inc., concerning securities purchased between September 12, 2025, and February 17, 2026, alleging significant misstatements and omissions in the company's IPO registration statement and prospectus, potentially leading to investor losses.
- Stock Price Plunge: Following the announcement of a 25% workforce reduction and exit from several international markets, GEMI's stock fell 8.72% to close at $6.70 per share on February 5, 2026, and further dropped 12.9% to $6.585 per share on February 17, 2026, due to executive departures and rising operating expenses, indicating strong market concerns about the company's future.
- Investor Action: Affected investors must apply for lead plaintiff status by May 18, 2026, to represent other investors in the lawsuit, with Kessler Topaz Meltzer & Check, LLP offering free case evaluations and operating on a contingency fee basis, ensuring no upfront costs.
- Deteriorating Financial Outlook: At the time the lawsuit was filed, GEMI's stock traded at $5.96 per share, reflecting a staggering 78.7% decline from its IPO price of $28.00, highlighting a significant loss of market confidence and necessitating careful risk assessment for future investments.
See More











